Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide does not directly damage teeth, but several indirect effects of the medicine can influence oral health. Dry mouth, acid reflux, and frequent vomiting (all common at the start of treatment) change the oral environment in ways that dentists recognise as risk factors for enamel erosion and gum sensitivity. This is not unique to Wegovy; it reflects how GLP-1 medicines alter digestion and saliva flow. These medicines are prescription-only and require a clinical assessment before any prescriber can decide whether they are suitable for you, which is exactly where questions like this one belong. For a fuller look at how semaglutide is licensed and used in the UK, the semaglutide overview page is a good starting point.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It's a specific, slightly unsettling thing to notice. Your teeth feel more sensitive, your mouth seems drier than usual, or you're getting more heartburn than you expected. These are not imagined. Semaglutide slows the rate at which your stomach empties, and that change in gastric motility has real upstream consequences. Saliva production can be reduced slightly, and nausea (which is very common in the first few weeks) sometimes leads to vomiting or regular acid reflux. Both acid reflux and vomit carry stomach acid into the mouth. Repeated exposure to that acid softens enamel, the hard outer layer of each tooth. Dentists call this acid erosion, and it is the same process that concerns them in people with frequent reflux for any reason, not just semaglutide.
The good news is that this mechanism is manageable once you understand it. Rinsing your mouth with water (not brushing immediately) after any vomiting episode, staying well hydrated through the day, and telling your dentist you are on a GLP-1 medicine means they can monitor for early signs. The Wegovy treatment page sets out more about how semaglutide works and what the licensed indications look like in the UK.
There is no clinical trial demonstrating that Wegovy directly causes tooth decay or gum disease. The STEP 1 trial, which enrolled over 1,900 adults with obesity and ran for 68 weeks, reported gastrointestinal events as the dominant side-effect category, with nausea affecting around 44% of participants on semaglutide and vomiting around 24%. Oral or dental effects were not identified as a distinct adverse-event category. That absence matters: it suggests direct dental damage is not a predictable, common outcome of treatment.
What does appear in the prescribing information and NHS guidance is the indirect chain described above. The NHS medicines page for semaglutide lists nausea, vomiting, diarrhoea, constipation, and heartburn as common side effects, each of which, if severe or prolonged, creates the oral-environment conditions that dentists would want to know about. The practical implication is that you should treat dental health as part of your overall response to treatment, not separately from it.
If you have questions about how semaglutide interacts with other parts of your physiology, the page on semaglutide and blood work covers a related set of systemic effects that often come up alongside this one.
Dry mouth (the clinical term is xerostomia) has a surprisingly large impact on dental health. Saliva is not passive. It neutralises acids, remineralises softened enamel between meals, washes away food debris, and keeps bacterial populations in check. When saliva flow drops, all four of those protective functions weaken. Some people on semaglutide report dry mouth, particularly in the early weeks of treatment and around dose increases.
If this is something you're experiencing, sipping water through the day is more useful than large amounts at mealtimes (which can worsen nausea on this medicine). Sugar-free gum stimulates saliva production and is broadly recommended for dry-mouth management by dental professionals. Avoiding alcohol-based mouthwashes, which can dry the mucosa further, is sensible. And if symptoms persist beyond the initial adjustment period, a dentist can assess whether any protective intervention (fluoride varnish, a different mouthwash formulation) is appropriate. Questions about other unexpected effects people notice are also worth raising; some find it useful to read about semaglutide and sleep, another area where indirect mechanisms are at play.
Most people on semaglutide do not develop significant dental problems. The risk is real but manageable, and it is highest for those whose nausea and reflux are frequent and prolonged rather than mild and transient. A few straightforward habits significantly reduce it: rinse with water after any vomiting (wait 30 minutes before brushing); keep up twice-daily fluoride toothpaste use; book a routine dental check and mention your medication; tell your prescriber if GI side effects are severe enough to be affecting daily life, because dose management or timing adjustments may help.
Severe or persistent tooth pain, bleeding gums that are getting worse, or noticeable changes to your bite or dental surface should be seen by a dentist and flagged to whoever manages your semaglutide prescription. These are not expected outcomes of treatment. The Wegovy and tooth pain page covers that more specific scenario in detail, and the Wegovy and eye effects page addresses another set of sensory questions that often arise alongside dental ones.
Cost is a reasonable part of thinking through any private treatment. The Wegovy pricing page sets out what private treatment typically involves, including what a transparent all-in price should cover. If you want to discuss your specific circumstances with a prescriber (including whether semaglutide is clinically right for you) you can start a free consultation with our prescribers at any point. Our clinical team reviews every consultation the same day it's submitted; a real clinician reads your answers, not a queue for an automated system.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.